← Back to All Filings

Albemarle GC Sells $10.9k in Stock Under Pre-Arranged Plan

Low SignificanceOctober 14, 2025 at 4:38:58 PM EDT

ALBEMARLE CORP

$ALB4CIK: 0000915913

Subscribe to track ALB

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Albemarle GC Sells $10.9k in Stock Under Pre-Arranged Plan

Company: ALBEMARLE CORP (ALB) Form: 4 | Filed: 2025-10-14 Significance: Low

Insider: Krupa Ander C. Title: General Counsel & Sec | Relationship: Officer

Transaction: • Type: Sell • Shares: 116 • Price: $95.00 • Value: $10,920 • Owned After: 11,655

Key Insight: This is a minor sale executed under a pre-scheduled Rule 10b5-1 trading plan, indicating it was not based on immediate market sentiment. The small transaction size has minimal significance.

Market Context: The sale was planned in March 2025, well before the transaction date, reducing its informational value regarding the company's current performance.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: ALBEMARLE CORP (ALB)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The General Counsel of Albemarle Corp sold a small amount of stock ($10,920) under a pre-established Rule 10b5-1 trading plan, making the transaction of low informational value.
  • Market Impact: The market impact is expected to be neutral given the small size of the transaction and its pre-planned nature, which mitigates concerns of opportunistic selling.

Company Information

FieldValue
CompanyALBEMARLE CORP
Ticker SymbolALB
CIK0000915913
IndustryPlastics, Materials, Synth Resins & Nonvulcan Elastomers [2821]

Insider Information

FieldValue
NameKrupa Ander C.
CIK0002077449
Title/PositionGeneral Counsel & Sec
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-10-09
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved116
Price Per Share$95.00
Total Value$10,920
Shares Owned After11,655
Ownership TypeDirect

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction value is nominal for a corporate executive. More importantly, the sale was conducted under a Rule 10b5-1 plan, which allows insiders to set up a trading plan for selling stocks at a predetermined time. This removes the element of the trade being based on recent, non-public information.

Volume & Sentiment

  • Expected Volume Impact: Negligible. A transaction of 116 shares will not be noticeable in the stock's daily trading volume.
  • Sentiment Indicator: Neutral. The pre-planned nature of the sale and its small size are unlikely to influence investor sentiment.

Investment Insights

Positive Market Indicators

  • The insider still holds a significant position of 11,655 shares after the sale, indicating continued alignment with shareholder interests.

Risk Factors

  • While this specific trade is not a concern, investors should monitor for any larger, non-planned sales from key executives in the future.

Key Takeaways

  1. Low Significance Sale: The total value of $10,920 is immaterial.
  2. Pre-Planned Transaction: The sale was executed under a Rule 10b5-1 plan adopted months prior, indicating it was likely for personal financial planning (e.g., tax obligations, diversification) rather than a reaction to company events.
  3. No Bearish Signal: This filing does not provide a bearish signal for Albemarle Corp due to the context surrounding the trade.

Contextual Analysis

Timing Significance

There is no particular timing significance. The transaction date was determined by the 10b5-1 plan established on March 13, 2025.

Transaction Context

As stated in footnote 1 of the filing, "The sale reported in this Form 4 was effectuated pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2025, prior to the Reporting Person becoming an Executive Officer." This context is critical as it detaches the sale from the insider's day-to-day assessment of the company's prospects.

Company Context

Analysis should be viewed in the context of Albemarle's recent performance, industry trends in specialty chemicals and lithium, and any recent company announcements. This isolated, small, pre-planned sale offers little insight into those broader factors.

Risk Assessment

Risk Level: Low

Risk Factors

  • The primary risk associated with insider sales (that insiders are selling because they anticipate a price drop) is almost entirely mitigated here.

Market Considerations

  • The market generally discounts or ignores small sales made under 10b5-1 plans.
  • Focus should remain on fundamental company metrics, earnings reports, and industry outlook rather than this specific filing.

IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.

Analysis generated on 2025-10-14 | Data source: SEC EDGAR

Topics:#SECFiling#InsiderTrading#ALB#ALBStock#Form4#InsiderSell#LowSignificance#StockMarket#Investing#FinancialAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.